NCT01240655View on ClinicalTrials.gov

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Solid Tumors
Interventions
DRUG

LCL161

DRUG

Paclitaxel

Trial Locations (7)

27514

University of North Carolina Lineberger Comp Cancer Ctr, Chapel Hill

37203

Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2), Nashville

41100

Novartis Investigative Site, Modena

02215

Dana Farber Cancer Institute SC, Boston

V5Z 1L3

Novartis Investigative Site, Vancouver

08035

Novartis Investigative Site, Barcelona

08036

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY